- Home
- SNPX vs IMCC Comparison
SNPX vs IMCC Comparison
Compare SNPX & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNPX
- IMCC
- Stock Information
- Founded
- SNPX 2012
- IMCC 1980
- Country
- SNPX United States
- IMCC Israel
- Employees
- SNPX N/A
- IMCC N/A
- Industry
- SNPX Medicinal Chemicals and Botanical Products
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- SNPX Health Care
- IMCC Health Care
- Exchange
- SNPX Nasdaq
- IMCC Nasdaq
- Market Cap
- SNPX 3.8M
- IMCC 5.0M
- IPO Year
- SNPX N/A
- IMCC N/A
- Fundamental
- Price
- SNPX $3.01
- IMCC $2.28
- Analyst Decision
- SNPX Strong Buy
- IMCC
- Analyst Count
- SNPX 1
- IMCC 0
- Target Price
- SNPX $14.00
- IMCC N/A
- AVG Volume (30 Days)
- SNPX 39.8K
- IMCC 10.4K
- Earning Date
- SNPX 08-14-2024
- IMCC 08-14-2024
- Dividend Yield
- SNPX N/A
- IMCC N/A
- EPS Growth
- SNPX N/A
- IMCC N/A
- EPS
- SNPX N/A
- IMCC N/A
- Revenue
- SNPX N/A
- IMCC $36,445,402.00
- Revenue This Year
- SNPX N/A
- IMCC $22.59
- Revenue Next Year
- SNPX N/A
- IMCC $20.53
- P/E Ratio
- SNPX N/A
- IMCC N/A
- Revenue Growth
- SNPX N/A
- IMCC N/A
- 52 Week Low
- SNPX $2.72
- IMCC $1.13
- 52 Week High
- SNPX $11.48
- IMCC $8.10
- Technical
- Relative Strength Index (RSI)
- SNPX 40.82
- IMCC 40.33
- Support Level
- SNPX $2.72
- IMCC $2.20
- Resistance Level
- SNPX $3.67
- IMCC $2.38
- Average True Range (ATR)
- SNPX 0.28
- IMCC 0.19
- MACD
- SNPX -0.04
- IMCC -0.04
- Stochastic Oscillator
- SNPX 33.58
- IMCC 12.30
About SNPX Synaptogenix Inc.
Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.